Metamizol Viatris

Metamizole Magnesium, the active ingredient in Metamizol Viatris, is a pyrazolone analgesic presented as an oral formulation for oral use. It is employed to relieve moderate to severe pain and to reduce fever in adult patients.

GNH USA supplies Metamizol Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to European Union quality standards and provides reliable logistics for bulk and parcel shipments across multiple continents. Customer support includes regulatory assistance and documentation for import clearance.

Metamizol Viatris, a pyrazolone analgesic, is used to manage conditions involving pain and fever. - Pain: Provides effective relief of moderate to severe acute pain. - Fever: Reduces elevated body temperature associated with infectious or inflammatory processes. - Postoperative pain: Controls pain following surgical procedures. - Colic: Alleviates visceral pain such as renal or biliary colic.

Metamizol Viatris may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Vomiting: occasional emesis. - Dizziness: transient light‑headedness. - Hypotension: temporary drop in blood pressure. - Rash: mild skin erythema.

Serious or Rare Side Effects: - Agranulocytosis: severe reduction of white blood cells, potentially life‑threatening. - Stevens‑Johnson syndrome: rare severe skin reaction. - Anaphylaxis: acute allergic response with respiratory compromise.

When prescribing Metamizol Viatris, clinicians should observe several safety measures. - Baseline blood count: Obtain a complete blood count before initiating therapy. - Monitor for allergic reactions: Observe patients for signs of rash or anaphylaxis. - Renal impairment: Adjust use in patients with reduced kidney function. - Pregnancy: Use only if